Working PaperArticleVersion 1This version is not peer-reviewed
Effect of New Analogs of Hexyloxy Phenyl Imidazoline on Quorum Sensing in Chromobacterium violaceum and In Silico Analysis of Ligand-Receptor Interactions
Version 1
: Received: 1 May 2019 / Approved: 6 May 2019 / Online: 6 May 2019 (08:59:08 CEST)
How to cite:
Herrera-Arizmendi, J.L.; Curiel-Quesada, E.; Correa-Basurto, J.; Bello, M.; Reyes-Arellano, A. Effect of New Analogs of Hexyloxy Phenyl Imidazoline on Quorum Sensing in Chromobacterium violaceum and In Silico Analysis of Ligand-Receptor Interactions. Preprints2019, 2019050042
Herrera-Arizmendi, J.L.; Curiel-Quesada, E.; Correa-Basurto, J.; Bello, M.; Reyes-Arellano, A. Effect of New Analogs of Hexyloxy Phenyl Imidazoline on Quorum Sensing in Chromobacterium violaceum and In Silico Analysis of Ligand-Receptor Interactions. Preprints 2019, 2019050042
Herrera-Arizmendi, J.L.; Curiel-Quesada, E.; Correa-Basurto, J.; Bello, M.; Reyes-Arellano, A. Effect of New Analogs of Hexyloxy Phenyl Imidazoline on Quorum Sensing in Chromobacterium violaceum and In Silico Analysis of Ligand-Receptor Interactions. Preprints2019, 2019050042
APA Style
Herrera-Arizmendi, J.L., Curiel-Quesada, E., Correa-Basurto, J., Bello, M., & Reyes-Arellano, A. (2019). Effect of New Analogs of Hexyloxy Phenyl Imidazoline on <em>Quorum Sensing</em> in <em>Chromobacterium violaceum</em> and <em>In Silico</em> Analysis of Ligand-Receptor Interactions. Preprints. https://doi.org/
Chicago/Turabian Style
Herrera-Arizmendi, J.L., Martiniano Bello and Alicia Reyes-Arellano. 2019 "Effect of New Analogs of Hexyloxy Phenyl Imidazoline on <em>Quorum Sensing</em> in <em>Chromobacterium violaceum</em> and <em>In Silico</em> Analysis of Ligand-Receptor Interactions" Preprints. https://doi.org/
Abstract
The increasingly common occurrence of antibiotic-resistant bacteria has become an urgent public health issue. There are currently some infections without any effective treatment, which require new therapeutic strategies. An attractive alternative is the design of compounds capable of disrupting bacterial communication known as quorum sensing (QS). In gram-negative bacteria, such communication is regulated by acyl-homoserine lactones (AHLs). QS allows bacteria to proliferate before expressing virulence factors. Our group previously reported that hexyloxy phenyl imidazoline (9) demonstrated 71% inhibitory activity of QS at 100 µM (IC50=90.9 µM) in Chomobacterium violaceum, a gram-negative bacterium. The aim of the present study was to take 9 as a lead compound to design and synthesize three 2-imidazolines (13-15) and three 2-oxazolines (16-18), to be evaluated as quorum sensing inhibitors on C. violaceum CV026. We were looking for compounds with a higher affinity towards the Cvi receptor of this bacterium and the ability to inhibit QS. The binding mode of the test compounds on the Cvi receptor was explored with docking studies and molecular dynamics. It was found that 8-pentyloxyphenyl-2-imidazoline 13 reduced the production of violacein (IC50=56.38 µM) without affecting bacterial growth, suggesting inhibition of quorum sensing. Indeed, compound 13 is apparently one of the best QS inhibitors known to date. Molecular docking revealed the affinity of compound 13 for the orthosteric site of the N-hexanoyl homoserine lactone (C6-AHL) on the CviR protein. Ten aminoacid residues in the active site of C6-AHL interacted with 13, and 7 of these are the same as those interacting with AHL. Contrarily, 8-octyloxyphenyl-2-imidazoline 14, 8-decyloxyphenyl-2-imidazoline 15 and 9-decyloxyphenyl-2-oxazoline 18 bound only to an allosteric site and thus did not compete with C6-AHL for the orthosteric site.
Chemistry and Materials Science, Medicinal Chemistry
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
